KELLY ROBERTS: Open Payments
NPI 1699382465 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,523 in 52 payments from 21 companies in 2025. Trend: 2023 $277 · 2024 $863 · 2025 $1,523
Food & beverage: $1,523
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $334 |
| Dexcom, Inc. | 12 | $266 |
| Averitas Pharma Inc. | 3 | $140 |
| Tandem Diabetes Care, Inc. | 1 | $101 |
| Amgen Inc. | 5 | $87 |
| Abbott Laboratories | 3 | $87 |
| Insulet Corporation | 1 | $80 |
| KYOWA KIRIN, INC. | 2 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52 |
| Soleno Therapeutics, Inc. | 2 | $48 |
Products named: Dexcom G6 Transmitter, Wegovy, QUTENZA, t:slim X2 Insulin Pump with Control-IQ, FREESTYLE LIBRE 3, Omnipod, Ozempic, JARDIANCE.
Industry payments across NV — which companies pay providers there.
